Trademark Overview
On Thursday, August 8, 2024, a trademark application was filed for DROPSHOT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DROPSHOT THERAPEUTICS trademark a serial number of 98688672. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 23, 2025. This trademark is owned by Dropshot Therapeutics LLC. The DROPSHOT THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services for organ perfusion, namely, gene modification; Medical services for organ perfusion via a procedure; Medical and health services in the fields of DNA analysis and testing, genetics and genetic testing; Medical diagnostic services for testing DNA, RNA, and protein samples for diseased cells; Genetic testing and diagnostic reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic medical analysis and diagnostic reporting services for medical purposes; Medical evaluation of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness for patients
Genome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins in raw material form for scientific and pharmaceutical research in the fields of gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction; Engineered proteins in raw material form for use in scientific research and analysis in the fields of genetic diseases, gene therapy, gene modification and cell therapy; chemical reagents, reagents, enzymes, as well as kits primarily comprised of enzymes and nucleotide monomers and also containing solid phase synthesis media and synthesis plates for laboratory use, all for use in scientific research specific to synthesizing polynucleotides, and more specifically for research related to amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells
Medical devices and apparatus for the delivery of therapeutic agents; Medical devices and apparatus for the delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for perfusing organs inside or outside human bodies for use in artificial organ support; Medical apparatus for use in organ perfusion for gene modification; Testing instruments for medical diagnostic purposes, namely, medical diagnostic apparatus for analyzing the genetic characteristics of body fluids, tissue samples and liquid biopsies for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Medical apparatus for gene modification, namely, in vitro diagnostic labeled quantitative polymerase chain reaction test kits for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system disea...
Laboratory and scientific apparatus and instruments in the nature of spectrophotometers for measuring relative DNA, RNA and protein, fluorometric quantifiers, capillary electrophoresis apparatus, gel electrophoresis apparatus, DNA and RNA fragment analyzers, thermocyclers for research use, Polymerase Chain Reaction (PCR) testing machines, real-time quantitative Polymerase Chain Reaction (qPCR) testing instruments, reverse transcription quantitative Polymerase Chain Reaction (qPCR) testing instruments, digital quantitative Polymerase Chain Reaction (qPCR) testing instruments, isothermal amplification devices for use in nucleic acid amplification, electroporators, nucleofectors, microinjection apparatus with micromanipulators, transfection instruments for delivering nucleic acids into cells, microfluidic transfection aparatus for delivering nucleic acids into cells, microfluidic droplet devices, next-generation nucleic acid sequencers, all used for storing nucleic acid molecules, and for...
Scientific research and development of therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; scientific research in the field of gene editing technology; Scientific research and development, namely, gene modification, as well as gene regulation and gene editing, for researching and developing modified human tissue cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research information and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, ge...
Therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical preparations for the treatme...
